About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:4360179
Allelic
Composition
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
Genetic
Background
FVB-Tg(Cryaa-TAg,Ins2-CALM1)26Ove
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Cryaa-TAg,Ins2-CALM1)26Ove mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• swollen mitochondria and broken mitochondrial double membranes are observed
• hearts have increased mitochondrial mass, as well as greater area and number
• respiratory control ratio (RCR) and state 3 respiration are significantly impaired in mitochondria

cardiovascular system
• hearts have many focal areas of damage with swollen mitochondria, mottled matrix and broken mitochondrial double membranes
• progressive increase in renal vascular resistance beginning at 3 months of age
• diastolic blood pressure is elevated in conscious mutants at 3 months of age when measured using a tail-cuff monitor
• by 8 months of age, both diastolic and systolic blood pressure is increased in conscious mutants
• under anesthesia, when measured by intravascular connulation, mutants exhibit a similar blood pressure to anesthetized controls, however this is reduced compared to conscious mutants

homeostasis/metabolism
• blood glucose levels are more than 2-fold higher than normal by 20 days after birth and continue to rise until at least 60 days of age (J:94602)
• some mutants develop hypoalbuminemia due to excessive loss of albumin
• albumin excretion rate increases progressively with age and exceeds 15,000 ug/24 hr at 9 months of age

adipose tissue
• loss of fat tissue by 5 months of age

growth/size/body
N
• mutants exhibit normal weight gain and body weight
• loss of fat tissue by 5 months of age
• 2-fold increase in kidney weight between 2 and 5 months of age

liver/biliary system

renal/urinary system
• progressive increase in renal vascular resistance beginning at 3 months of age
• albumin excretion rate increases progressively with age and exceeds 15,000 ug/24 hr at 9 months of age
• kidney shows dilation of the ducts, atrophy of tubular cells, protein casts in the duct lumen, and prominent infiltration of mononuclear cells
• 2-fold increase in kidney weight between 2 and 5 months of age
• glomeruli exhibit a thickened and irregular basement membrane
• expanded mesangium showing enlarged mesangial fraction and mesangial volume, with the greatest rate increase during 2.5-6 months of age
• diffuse and nodular expansion of mesangial matrix in mutants over 2 months of age
• diffuse and nodular glomerulosclerotic lesions
• nodules are acellular and are similar to Kimmelsteil-Wilson lesions in size
• glomerular volume is enlarged, with the greatest rate increase during 2.5-6 months of age
• seen in many mutants over 5 months of age
• expansion of kidney tubules; average cortical tubule cross-sectional area (minus the lumen) is 34% greater in 9 month old mutants than controls
• significant fibrosis in the kidney by 5 months of age
• tubulointerstitial fibrosis
• many mutants over 5 months of age exhibit bladder stasis
• distended bladders are seen in many mutants over 5 months of age
• glomerular filtration rate increases significantly from 2 to 3 months of age but then decreases significantly from 5 to 9 months of age
• decline in glomerular filtration rate coincides with an increase in renal vascular resistance
• by 2 months of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
type 1 diabetes mellitus DOID:9744 OMIM:222100
J:94602


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory